DOW JONES28,992.41-227.57 -0.78%
S&P 5003,337.75-35.48 -1.05%
NASDAQ9,576.59-174.38 -1.79%

Morgan Stanley Upgrades Neon Therapeutics to Equal-Weight, Maintains $2.18 Price Target

Morgan Stanley upgrades Neon Therapeutics (NASDAQ:NTGN) from Underweight to Equal-Weight and maintains $2.18 price target.

Benzinga · 01/21/2020 13:53

Morgan Stanley upgrades Neon Therapeutics (NASDAQ:NTGN) from Underweight to Equal-Weight and maintains $2.18 price target.